HUMC performs first prostate cancer treatment with Focal One Robotic HIFU

Hackensack Meridian Hackensack University Medical Center recently performed the first prostate cancer treatments with Focal One Robotic HIFU driven by Philips DynaCAD Urology platform.

Dr. Kevin Basralian, director of diagnostic and focal prostate cancer therapies at HUMC and Dr. Nitin Yerram, director of Urologic Research and co-director of Urologic Oncology for the John Theurer Cancer Center at HUMC, performed the first treatments at the medical center.

The urology team plans to broadcast a procedure showing the integration of these two technologies in a private, urologist-only live Focal One procedure event during “Movember” – Men’s Health Awareness Month.

“This technology will allow us to continue our advances in providing precision care for men diagnosed with prostate cancer that is tailored to each patient’s unique needs,” Basralian said. “This is critical now more than ever as we face the growing challenge of this disease in the United States.”

Yerram agreed.

“We are proud to be the first team to perform a Focal One procedure driven by data export from the innovative Philips DynaCAD Urology system,” he said “The combination of these cutting-edge tools provides unparalleled clarity and precision and drives workflow efficiency by extending the diagnostic data into treatment procedures allowing me to offer my patients the most accurate diagnoses and personalized treatment plans possible.”